Leading UK-RTC Member Ramps up Capacity

Diagnostics business developer Abingdon Health has announced further expansion at its York headquarters in the UK, following further investment in its lateral flow automation technology. This will provide a significant increase in its manufacturing footprint, resulting in Europe’s largest capacity for rapid test manufacturing. This news comes weeks after the UK Government announced Abingdon Health as one of the leading members of the UK Rapid Test Consortium (UK-RTC).

Earlier this year, Abingdon Health announced a preliminary round of expansion in York after 90% revenue growth in 2019, following new assay developments and assay manufacturing contract wins, along with introduction of its AppDx Smartphone reader software. In April 2020, growth continued with the acquisition of a new lateral flow manufacturing facility in Doncaster, UK. The combined capacity of both sites is capable of producing millions of rapid tests per month for clients across many industries, the company said. 

Michael Hunter, Operations Director of Abingdon Health, commented: “The additional footprint and automation come at a timely moment as demand for rapid tests is growing rapidly, with the market likely to exceed $10bn globally. Our precision automation and multi-site approach means we can adapt to meet the varying manufacturing needs of our growing global client base.”